NCT02233348 is a clinical trial in Autism Spectrum Disorder, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT02233348?

NCT02233348 is sponsored by National Taiwan University Hospital.

What condition does NCT02233348 study?

NCT02233348 studies Autism Spectrum Disorder.

Is NCT02233348 still recruiting?

NCT02233348 is currently completed. Last updated 2 September 2021.

Last reviewed 2021-09-02 · How we verify

NCT02233348

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurocognitive and Psychosocial Outcome of Youths With Autism Spectrum Disorder

Completed Last updated 2 September 2021

What this trial tests

trial in Autism Spectrum Disorder in 523 participants. Completed in 31 December 2019.

Timeline

1 January 2015

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	523
Start date	1 January 2015
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Taiwan

Conditions studied

Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →

Sponsor

National Taiwan University Hospital

Who can join

Adults 10 to 25, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autism spectrum disorders (ASD) is a common childhood-onset, multi-factorial, highly heritable, clinically and genetically heterogeneous, neurodevelopmental disorder. Due to its high prevalence and severe lifelong impairment without effective prevention and treatment, there is a dearth of investigating its pathogenesis, longitudinal outcome, and biomarkers (endophenotypes). The ultimate goals of this 5-year project are to prospectively investigate the outcome and changes of psychosocial and neurocognitive functions of a cohort of probands with ASD at adolescence and young adulthood as the primary aim; and to test whether structural and functional brain connectivity can be effective endophenotypes of ASD using the unaffected sibling and follow-up designs as the secondary aims.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Development of frontoparietal connectivity predicts longitudinal symptom changes in young people with autism spectrum disorder.
Lin HY, Perry A, Cocchi L, Roberts JA, et al · · 2019 · cited 39× · PMID 30755585 · DOI 10.1038/s41398-019-0418-5
Exploring social emotion processing in autism: evaluating the reading the mind in the eyes test using network analysis.
Li TS, Gau SS, Chou TL. · · 2022 · cited 3× · PMID 35241030 · DOI 10.1186/s12888-022-03773-x
Developmental changes of visuospatial working memory in autistic children and adolescents.
Lin YJ, Wu YY, Tsai WC, Chang JC, et al · · 2025 · PMID 40685389 · DOI 10.1017/s0033291725000133

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02233348 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 2 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02233348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing